Sterinova Inaugurates $70mn Sterile Injectable Site in Canada

Saint-Hyacinthe plant will focus on development and manufacture of sterile ready-to-use injectable products

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Sterinova, a new pharmaceutical company specialized in the development and manufacture of sterile ready-to-use injectable products, has inaugurated its plant in Saint-Hyacinthe and will offer syringes or premix solutions containers. The new company, based in Saint-Hyacinthe, in the Montérégie region, is the result of a total investment of approximately $70 million, made by the Fonds de solidarité FTQ, Quebec Manufacturing Fund (QMF), Saint-Hyacinthe Technopole through the Pharmaceutical Devel...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters